Personalis, Inc. Common Stock
N/A
USD
N/A
N/A
...
Chart
Financials
Description
PSNL Company Description
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
PSNL Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view PSNL Smart Score
Score Breakdown
PSNL Company Description
Show More
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of PSNL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by PSNL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on PSNL's company Twitter account
WallStreetBets
Number of mentions of PSNL in WallStreetBets Daily Discussion
PSNL News
Recent insights relating to PSNL
CNBC Recommendations
Recent picks made for PSNL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in PSNL
Corporate Flights
Flights by private jets registered to PSNL
Our Analysis